BMP-2 signaling in ovarian cancer and its association with poor prognosis

BMP-2 signaling in ovarian cancer and its association with poor prognosis

<p>Abstract</p> <p>Background</p> <p>We previously observed the over-expression of BMP-2 in primary cultures of epithelial ovarian cancer (EOC) cells as compared to normal epithelial cells based on Affymetrix microarray profiling <abbrgrp><abbr bid="B1&quo...

Full description

Bibliographic Details
Main Authors:	Le Page Cécile, Puiffe Marie-Line, Meunier Liliane, Zietarska Magdalena, de Ladurantaye Manon, Tonin Patricia N, Provencher Diane, Mes-Masson Anne-Marie
Format:	Article
Language:	English
Published:	BMC 2009-04-01
Series:	Journal of Ovarian Research
Online Access:	http://www.ovarianresearch.com/content/2/1/4

Similar Items

Characterization of Ovarian Cancer Ascites on Cell Invasion, Proliferation, Spheroid Formation, Gene Expression in an In Vitro Model of Epithelial Ovarian Cancer
by: Marie-Line Puiffe, et al.
Published: (2007-10-01)

Characterization of three new serous epithelial ovarian cancer cell lines
by: Hébert Josée, et al.
Published: (2008-05-01)

A COEUR cohort study of SATB2 expression and its prognostic value in ovarian endometrioid carcinoma
by: Cécile Le Page, et al.
Published: (2019-07-01)

Influence of monolayer, spheroid, and tumor growth conditions on chromosome 3 gene expression in tumorigenic epithelial ovarian cancer cell lines
by: Provencher Diane M, et al.
Published: (2008-08-01)

Predictive and Prognostic Protein Biomarkers in Epithelial Ovarian Cancer: Recommendation for Future Studies
by: Cécile Le Page, et al.
Published: (2010-05-01)

Subtype specific elevated expression of hyaluronidase-1 (HYAL-1) in epithelial ovarian cancer.
by: Paule Héléna Yoffou, et al.
Published: (2011-01-01)

Modeling the Diversity of Epithelial Ovarian Cancer through Ten Novel Well Characterized Cell Lines Covering Multiple Subtypes of the Disease
by: Alexandre Sauriol, et al.
Published: (2020-08-01)

An essential role for Ran GTPase in epithelial ovarian cancer cell survival
by: Provencher Diane M, et al.
Published: (2010-10-01)

Expression of Stem Cell Markers in Preinvasive Tubal Lesions of Ovarian Carcinoma
by: G. Chene, et al.
Published: (2015-01-01)

A Keratin 7 and E-Cadherin Signature Is Highly Predictive of Tubo-Ovarian High-Grade Serous Carcinoma Prognosis
by: Laudine Communal, et al.
Published: (2021-05-01)

Derivation and characterization of matched cell lines from primary and recurrent serous ovarian cancer
by: Létourneau Isabelle J, et al.
Published: (2012-08-01)

BTN3A2 expression in epithelial ovarian cancer is associated with higher tumor infiltrating T cells and a better prognosis.
by: Cécile Le Page, et al.
Published: (2012-01-01)

Ran GTPase: A Key Player in Tumor Progression and Metastasis
by: Zied Boudhraa, et al.
Published: (2020-05-01)

Characterization of EN-1078D, a poorly differentiated human endometrial carcinoma cell line: a novel tool to study endometrial invasion in vitro
by: Asselin Eric, et al.
Published: (2007-09-01)

Ran promotes membrane targeting and stabilization of RhoA to orchestrate ovarian cancer cell invasion
by: Kossay Zaoui, et al.
Published: (2019-06-01)

Contribution of the <it>PALB2</it> c.2323C>T [p.Q775X] Founder mutation in well-defined breast and/or ovarian cancer families and unselected ovarian cancer cases of French Canadian descent
by: Tischkowitz Marc, et al.
Published: (2013-01-01)

The genomic landscape of TP53 and p53 annotated high grade ovarian serous carcinomas from a defined founder population associated with patient outcome.
by: Paulina M Wojnarowicz, et al.
Published: (2012-01-01)

RAN nucleo-cytoplasmic transport and mitotic spindle assembly partners XPO7 and TPX2 are new prognostic biomarkers in serous epithelial ovarian cancer.
by: Katia Y Cáceres-Gorriti, et al.
Published: (2014-01-01)

Discovery of dachshund 2 protein as a novel biomarker of poor prognosis in epithelial ovarian cancer
by: Nodin Björn, et al.
Published: (2012-01-01)

Immunohistochemical profiling of benign, low malignant potential and low grade serous epithelial ovarian tumors
by: Rancourt Claudine, et al.
Published: (2008-11-01)

Expression Of BMP7 In Ovarian Cancer And Biological Effect Of BMP7 Knockdown On Ovarian Cancer Cells
by: Guan H, et al.
Published: (2019-09-01)

Carboplatin response in preclinical models for ovarian cancer: comparison of 2D monolayers, spheroids, ex vivo tumors and in vivo models
by: Melica Nourmoussavi Brodeur, et al.
Published: (2021-09-01)

Chromosome 3 anomalies investigated by genome wide SNP analysis of benign, low malignant potential and low grade ovarian serous tumours.
by: Ashley H Birch, et al.
Published: (2011-01-01)

GSG2 Promotes Development and Predicts Poor Prognosis of Ovarian Cancer
by: Huang Y, et al.
Published: (2021-01-01)

KCNH3 Predicts Poor Prognosis and Promotes Progression in Ovarian Cancer
by: Li Z, et al.
Published: (2020-10-01)

Cyclin H predicts the poor prognosis and promotes the proliferation of ovarian cancer
by: Chen Peng, et al.
Published: (2020-07-01)

NUAK1 (ARK5) is Associated with Poor Prognosis in Ovarian Cancer.
by: Neil T. Phippen, et al.
Published: (2016-10-01)

Carboplatin sensitivity in epithelial ovarian cancer cell lines: The impact of model systems.
by: Bishnubrata Patra, et al.
Published: (2020-01-01)

Haplotype analysis suggest common founders in carriers of the recurrent <it>BRCA2 </it>mutation, 3398delAAAAG, in French Canadian hereditary breast and/ovarian cancer families
by: Foulkes William D, et al.
Published: (2006-03-01)

Characteristics and outcome of the COEUR Canadian validation cohort for ovarian cancer biomarkers
by: Cécile Le Page, et al.
Published: (2018-03-01)

Elevated Expression of Glycerol-3-Phosphate Phosphatase as a Biomarker of Poor Prognosis and Aggressive Prostate Cancer
by: Mohamed Amine Lounis, et al.
Published: (2021-03-01)

YAP promotes ovarian cancer cell tumorigenesis and is indicative of a poor prognosis for ovarian cancer patients.
by: Yan Xia, et al.
Published: (2014-01-01)

Global gene expression analysis of early response to chemotherapy treatment in ovarian cancer spheroids
by: Tetu Bernard, et al.
Published: (2008-02-01)

Increased Expression of LYNX1 in Ovarian Serous Cystadenocarcinoma Predicts Poor Prognosis
by: Hui Liu, et al.
Published: (2020-01-01)

Gene expression profile association with poor prognosis in epithelial ovarian cancer patients
by: Douglas V. N. P. Oliveira, et al.
Published: (2021-03-01)

is a Marker for Poor Prognosis and a Potential Driver for Metastasis in Ovarian Carcinomas
by: Pichai Raman, et al.
Published: (2015-01-01)

Thy-1 predicts poor prognosis and is associated with self-renewal in ovarian cancer
by: Elizabeth V. Connor, et al.
Published: (2019-11-01)

Identification of significant genes with poor prognosis in ovarian cancer via bioinformatical analysis
by: Hao Feng, et al.
Published: (2019-04-01)

Higher expression of calcineurin predicts poor prognosis in unique subtype of ovarian cancer
by: Bing Xin, et al.
Published: (2019-08-01)

Low BCL7A expression predicts poor prognosis in ovarian cancer
by: Ziqian Sun, et al.
Published: (2019-05-01)